Real-World Experience of Monitoring Practice of Endocrinopathies Associated with the Use of Novel Targeted Therapies among Patients with Solid Tumors

Background: Cancer treatments have gradually evolved into targeted molecular therapies characterized by a unique mechanism of action instead of non-specific cytotoxic chemotherapies. However, they have unique safety concerns. For instance, endocrinopathies, which are defined as unfavorable metabolic...

Descripción completa

Detalles Bibliográficos
Autores principales: AlHarbi, Atika, Alshamrani, Majed, Khan, Mansoor, Alnatsheh, Abdelmajid, Aseeri, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680233/
https://www.ncbi.nlm.nih.gov/pubmed/36412906
http://dx.doi.org/10.3390/medsci10040065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680233/
https://www.ncbi.nlm.nih.gov/pubmed/36412906
http://dx.doi.org/10.3390/medsci10040065

Ejemplares similares